Literature DB >> 22708927

Selective mode of action of guanidine-containing non-peptides at human NPFF receptors.

Maria Findeisen1, Cäcilia Würker, Daniel Rathmann, René Meier, Jens Meiler, Roger Olsson, Annette G Beck-Sickinger.   

Abstract

The binding pocket of both NPFF receptors was investigated, focusing on subtype-selective behavior. By use of four nonpeptidic compounds and the peptide mimetics RF9 and BIBP3226, agonistic and antagonistic properties were characterized. A set of Ala receptor mutants was generated. The binding pocket was narrowed down to the upper part of transmembrane helices V, VI, VII and the extracellular loop 2. Positions 5.27 and 6.59 have been shown to have a strong impact on receptor activation and were suggested to form an acidic, negatively charged binding pocket in both NPFF receptor subtypes. Additionally, position 7.35 was identified to play an important role in functional selectivity. According to docking experiments, the aryl group of AC-216 interacts with position 7.35 in the NPFF(1) but not in the NPFF(2) receptor. These results provide distinct insights into the receptor specific binding pockets, which is necessary for the development of drugs to address the NPFF system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22708927      PMCID: PMC3404467          DOI: 10.1021/jm300535s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  53 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals.

Authors:  S Hinuma; Y Shintani; S Fukusumi; N Iijima; Y Matsumoto; M Hosoya; R Fujii; T Watanabe; K Kikuchi; Y Terao; T Yano; T Yamamoto; Y Kawamata; Y Habata; M Asada; C Kitada; T Kurokawa; H Onda; O Nishimura; M Tanaka; Y Ibata; M Fujino
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

3.  RosettaLigand docking with full ligand and receptor flexibility.

Authors:  Ian W Davis; David Baker
Journal:  J Mol Biol       Date:  2008-11-18       Impact factor: 5.469

4.  Neuropeptide FF receptors have opposing modulatory effects on nociception.

Authors:  Jelveh Lameh; Fabio Bertozzi; Nicholas Kelly; Paula M Jacobi; Derek Nguyen; Abhishek Bajpai; Gilles Gaubert; Roger Olsson; Luis R Gardell
Journal:  J Pharmacol Exp Ther       Date:  2010-03-30       Impact factor: 4.030

5.  Crystal structure of squid rhodopsin.

Authors:  Midori Murakami; Tsutomu Kouyama
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

6.  Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.

Authors:  Gilles Gaubert; Fabio Bertozzi; Nicholas M Kelly; Jan Pawlas; Audra L Scully; Norman R Nash; Luis R Gardell; Jelveh Lameh; Roger Olsson
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

Review 7.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

8.  Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice.

Authors:  Lionel Moulédous; Florent Barthas; Jean-Marie Zajac
Journal:  Neuropeptides       Date:  2010-06-15       Impact factor: 3.286

9.  The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF).

Authors:  E Y Huang; J Y Li; P P Tan; C H Wong; J C Chen
Journal:  Peptides       Date:  2000-02       Impact factor: 3.750

10.  VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.

Authors:  L Rihakova; C Quiniou; F F Hamdan; R Kaul; S Brault; X Hou; I Lahaie; P Sapieha; D Hamel; Z Shao; F Gobeil; P Hardy; J-S Joyal; H Nedev; F Duhamel; K Beauregard; N Heveker; H U Saragovi; G Guillon; M Bouvier; W D Lubell; S Chemtob
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-29       Impact factor: 3.619

View more
  1 in total

1.  Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors.

Authors:  V Blair Journigan; Christophe Mésangeau; Neha Vyas; Shainnel O Eans; Stephen J Cutler; Jay P McLaughlin; Catherine Mollereau; Christopher R McCurdy
Journal:  J Med Chem       Date:  2014-10-21       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.